Otonomy to Present at the J.P. Morgan Healthcare Conference
January 02 2019 - 4:05PM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that David A. Weber, Ph.D., president
and chief executive officer, will present at the 37th Annual J.P.
Morgan Healthcare Conference on Thursday, January 10, 2019 at 10:30
a.m. PT (1:30 p.m. ET) at the Westin St. Francis Hotel in San
Francisco.
A live audio webcast of the presentation and breakout question
and answer session will be available through the Events and
Presentations page of the company's website (www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for neurotology. The company
pioneered the application of drug delivery technology to the ear in
order to develop products that achieve sustained drug exposure from
a single local administration. This approach is covered by a broad
patent estate and is being utilized to develop a pipeline of
products addressing important unmet medical needs including
Ménière’s disease, hearing loss, and tinnitus. For additional
information please visit www.otonomy.com.
Contacts:
Media Inquiries Spectrum Leticia Diaz Vice President
202.587.2517 ldiaz@spectrumscience.com
Investor InquiriesWestwicke PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From May 2024 to Jun 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2023 to Jun 2024